As the COVID-19 pandemic eases, experts warn of an alarming rise in drug-resistant superbugs that pose a greater danger than the coronavirus. This antimicrobial resistance (AMR) has become a major global health threat, prompting urgent action to tackle the issue within the next decade. Superbugs, which include bacteria, viruses, fungi, and parasites, are evolving and becoming resistant to existing antibiotics, making infections harder to treat and increasing the risk of severe illness, death, and spread. Unlike COVID-19, AMR does not fade away with immunity or vaccines and requires comprehensive strategies to address this pressing public health concern.